Zyla Life Sciences (EGLT) Return on Assets ROA from the first quarter of 2020 to first quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Mar 31 2020 to Mar 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Zyla Life Sciences  (EGLT)


Zyla Life Sciences's ROA from the first quarter of 2020 to the first quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Zyla Life Sciences's ROA in the first quarter of 2020?
Zyla Life Sciences recorded a cumulative net loss of $-101 million during 12 months ending in the first quarter of 2020, resulting in a negative return on assets (ROA) of -43.45%.

However, within the Healthcare sector 515 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2020 quarter, so far to 4144, from total ROA ranking in the fourth quarter of 2019 at 4749.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Total Assets Change 53.12 % 276.58 % 229.2 % 135.62 % 34.51 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -101 -95 -62 -103 -95
Return On Assets (TTM) -43.45 % -44.74 % -36.31 % -79.53 % -99.65 %
EGLT's Total Ranking # 4144 # 4749 # 4173 # 4624 # 4777
Total Assets (TTM) in million 229 229 239 236 150
Seq. Total Assets Change 0.02 % -4.13 % 1.48 % 57.36 % 145.99 %
Seq. Net Income Change - - - - -

EGLT's 5 Years Annual ROA >> Back to EGLT Management Effectiveness >> Compare EGLT ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 220
Sector # 516
Overall # 4001

Return On Assets Statistics
High Average Low
-36.19 %
-62.94 %
-129.67 %
(Jun 30 2018)   (Mar 31 2019)





Financial Statements
Zyla Life Sciences's Assets $ 229 million EGLT's Balance sheet
Zyla Life Sciences's Income $ -18 million Quarterly EGLT's Income Statement
EGLT's Income by Division See EGLT's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015
Y / Y Total Assets Change 272.45 % -48.39 % 4.93 % -32.17 % 181.98 %
Total Assets in million 230 62 120 114 168
Y / Y Net Income Change - - - - -
Net Income in million -95 -95 -69 -91 -58
Annual Return On Assets -41.43 % -154.31 % -57.87 % -79.34 % -34.4 %

EGLT's 5 Years Annual ROA >> Back to EGLT Management Effectiveness >> Compare EGLT ROA to its Competitors



More Return On Assets Ratios
EGLT's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
EGLT's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for EGLT's Competitors
Subscribers only: Roa for Zyla Life Sciences's Suppliers
Subscribers only: Return On Assets for EGLT's Customers

You may also want to know
EGLT's Roi EGLT's Inventory Turnover Ratio EGLT's Growth Rates EGLT's Dividend Comparisons
EGLT's Profitability Ratios EGLT's Asset Turnover Ratio EGLT's Dividend Growth
EGLT's Roe EGLT's Valuation Ratios EGLT's Financial Strength Ratios EGLT's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2020, within Healthcare Sector ROA

Date modified: 2026-09-08T15:09:57+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.